rs374420253
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001609.4(ACADSB):c.621G>A(p.Trp207Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001609.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADSB | NM_001609.4 | c.621G>A | p.Trp207Ter | stop_gained | 5/11 | ENST00000358776.7 | NP_001600.1 | |
ACADSB | NM_001330174.3 | c.315G>A | p.Trp105Ter | stop_gained | 4/10 | NP_001317103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADSB | ENST00000358776.7 | c.621G>A | p.Trp207Ter | stop_gained | 5/11 | 1 | NM_001609.4 | ENSP00000357873 | P1 | |
ACADSB | ENST00000368869.8 | c.315G>A | p.Trp105Ter | stop_gained | 4/10 | 2 | ENSP00000357862 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251454Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135898
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727234
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74382
ClinVar
Submissions by phenotype
Deficiency of 2-methylbutyryl-CoA dehydrogenase Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 10, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 23, 2019 | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 299075). This premature translational stop signal has been observed in individual(s) with clinical features of ACADSB-related disorders (PMID: 26284228). This variant is present in population databases (rs374420253, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Trp207*) in the ACADSB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADSB are known to be pathogenic (PMID: 20547083, 26284228). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 22, 2024 | Variant summary: ACADSB c.621G>A (p.Trp207X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 6.4e-05 in 251454 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ACADSB causing Deficiency of 2-methylbutyryl-CoA Dehydrogenase (6.4e-05 vs 0.0011), allowing no conclusion about variant significance. c.621G>A has been reported in the literature in individuals affected with Deficiency of 2-methylbutyryl-CoA Dehydrogenase (examples: Alfardan_2010, Valencia_2015). The following publications have been ascertained in the context of this evaluation (PMID: 20547083, 26284228). ClinVar contains an entry for this variant (Variation ID: 299075). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 13, 2023 | Reported previously as a homozygous variant in a 4 year old asymptomatic patient initially identified on newborn screen who has persisted elevated C5-carnitine levels in blood (PMID: 20547083); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 21228398, 30730842, 31980526, 20547083, 26284228) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at